Title |
Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)
|
---|---|
Published in |
PLOS ONE, October 2013
|
DOI | 10.1371/journal.pone.0076298 |
Pubmed ID | |
Authors |
Ping-Yen Liu, Liang-Yu Lin, Hung-Ju Lin, Chien-Hsun Hsia, Yi-Ren Hung, Hung-I Yeh, Tao-Cheng Wu, Ju-Yi Chen, Kuo-Liong Chien, Jaw-Wen Chen |
Abstract |
Evidence about the efficacy and safety of statin treatment in high-risk patients with hypercholesterolemia is available for some populations, but not for ethnic Chinese. To test the hypothesis that treatment with pitavastatin (2 mg/day) is not inferior to treatment with atorvastatin (10 mg/day) for reducing low-density lipoprotein cholesterol (LDL-C), a 12-week multicenter collaborative randomized parallel-group comparative study of high-risk ethnic Chinese patients with hypercholesterolemia was conducted in Taiwan. In addition, the effects on other lipid parameters, inflammatory markers, insulin-resistance-associated biomarkers and safety were evaluated. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Korea, Republic of | 1 | 1% |
Netherlands | 1 | 1% |
Denmark | 1 | 1% |
Unknown | 94 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 16% |
Student > Bachelor | 13 | 13% |
Student > Ph. D. Student | 10 | 10% |
Researcher | 7 | 7% |
Other | 6 | 6% |
Other | 13 | 13% |
Unknown | 32 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 33% |
Biochemistry, Genetics and Molecular Biology | 7 | 7% |
Nursing and Health Professions | 7 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Agricultural and Biological Sciences | 3 | 3% |
Other | 9 | 9% |
Unknown | 34 | 35% |